GENESYS INTL CORPN LTD
GENESYS · General/Diversified · NSE
₹281
Current Market Price
Fair Value (DCF)
₹236
Margin of Safety
-16.0%
Updated just now
YieldIQ Score
48/100
Piotroski F-Score
4/9
Economic Moat
Wide
Confidence
24%
ROE
—
Debt/Equity
0.21
WACC
11.1%
Market Cap
₹1,173 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
15.5%
Return on capital employed
EV / EBITDA
11.5×
Enterprise multiple
Debt / EBITDA
1.1×
Leverage vs earnings
Interest Coverage
10.4×
EBIT covers interest
Current Ratio
2.41×
Short-term liquidity
Asset Turnover
0.40×
Revenue per ₹ of assets
Revenue CAGR (3Y)
38.7%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹280.6
Bear case
₹122.49
MoS -129.1%
Base case
₹235.66
MoS -19.1%
Bull case
₹273.44
MoS -2.6%
Ratio Trends
GENESYS · last 8 annual periods
ROE
10.1%
ROCE
21.6%
Operating Margin
—
Debt / Equity
0.22×
PE
72.0×
EV / EBITDA
21.5×
Historical Financials
GENESYS · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹79.6 Cr | ₹120 Cr | ₹46.6 Cr | ₹71.2 Cr | ₹311 Cr | +40.6% |
| EBITDA | — | ₹-14.3 Cr | ₹65.2 Cr | ₹85.6 Cr | ₹146 Cr | — |
| EBIT | ₹-51.5 Cr | ₹-36.4 Cr | ₹6.9 Cr | ₹25.5 Cr | — | — |
| PAT | ₹-51.8 Cr | ₹-41.1 Cr | ₹2.0 Cr | ₹14.8 Cr | ₹56.2 Cr | — |
| EPS (diluted) | ₹-13.34 | ₹4.13 | ₹0.61 | ₹3.75 | — | — |
| CFO | ₹18.5 Cr | ₹27.5 Cr | ₹-35.2 Cr | ₹19.1 Cr | ₹-52.9 Cr | — |
| CapEx | — | — | — | — | ₹-54.2 Cr | — |
| FCF | — | — | — | — | ₹-107 Cr | — |
| Total Assets | — | ₹319 Cr | ₹506 Cr | ₹635 Cr | ₹778 Cr | +25.0% |
| Total Debt | — | — | ₹15.0 Cr | ₹29.7 Cr | ₹122 Cr | +68.8% |
| Shareholders' Equity | — | — | ₹405 Cr | ₹489 Cr | ₹557 Cr | +8.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
GENESYS vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| IZMO IZMO LIMITED | -45.4% | 45 | Overvalued | 13.6% | — |
| UNIECOM UNIECOM | — | — | Pending | 25.2% | — |
| EXCELSOFT EXCELSOFT TECHNOLOGIES L | +2.1% | 70 | Fairly valued | 9.3% | — |
| RAMCOSYS RAMCO SYSTEMS LTD. | -53.8% | 52 | High Risk | -10.7% | — |
| KERNEX KERNEX | — | — | Pending | 31.9% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for GENESYS in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. GENESYS INTL CORPN LTD (GENESYS.NS) trades at 280.60 vs a model fair value of 235.66, a gap of -16.0%. Piotroski F-score: 4/9. Moat label...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of GENESYS →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for GENESYS →
Compare
Head-to-head with peers
Compare GENESYS side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse GENESYSNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.